Briefing Documents for Ataluren Ad Comm Released

The briefing documents for the September 28 Advisory Committee Meeting for PTC Therapeutic’s drug ataluren have been released. We will spend the next days reviewing all of the materials.

PPMD continues to work with PTC and with the families participating in the Open Public Hearing portion of the Ad Comm. This is our community’s opportunity to once again stand up and share our stories and our experiences with a therapy we believe is safe and effective.

Click here to access the briefing documents.



Views: 332


You need to be a member of PPMD Community to add comments!

Join PPMD Community

Need help using this community site? Visit Ning's Help Page.



© 2020   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service